(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL between May 30 and June 3 was host to the Poster Session: Genitourinary Cancer - Prostate, ...

Surgery risks have been highlighted in a new warning for users of popular diabetes and weight-loss drugs, including Ozempic ...

I know we wanna cheat the system as Americans, we do,” the 53-year-old tells Page Six in an exclusive interview.

Regeneron Pharmaceuticals Inc. is adding to its obesity pipeline by in-licensing Hansoh Biomedical Co. Ltd.’s phase III dual ...

The global interest in medical weight loss solutions has surged, driven by the success stories and clinical efficacy of medications like Ozempic and Wegovy. Originally developed for managing Type 2 ...

A study of real-world and virtual patients suggests that a less frequent dosing of glucagon-like peptide 1 receptor agonists ...

Richard Siegel, MD, is a double board-certified endocrinologist, the Co-Director of the Diabetes and Lipid Center at Tufts ...

Ozempic teeth is the latest concern associated with the ‘miracle’ weight loss drug Ozempic Read to know more about this side ...

Regeneron Pharmaceuticals is to enter an in-licensing agreement with Hansoh Pharmaceuticals to secure exclusive rights for HS ...

Bengaluru: Biocon Limited, a global biopharmaceutical company, has announced that the company has received approval in India ...

Mazdutide, used in the treatment of obesity and metabolic diseases, could become the first domestically-developed dual-target ...

The direct-to-consumer telehealth company said the workforce reduction is unrelated to its weight-loss drug sector.